• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肾和小脑中的神经酰胺酶与神经酰胺合成。一种新型碱性神经酰胺酶的描述。

Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.

作者信息

Sugita M, Willians M, Dulaney J T, Moser H W

出版信息

Biochim Biophys Acta. 1975 Jul 22;398(1):125-31. doi: 10.1016/0005-2760(75)90176-9.

DOI:10.1016/0005-2760(75)90176-9
PMID:238641
Abstract

It has been shown that tissues of patients with Farber's disease characteristically lack acid (pH 4.0) ceramidase. In normal cerebellum, however, ceramide cleavage and the reverse reaction, free fatty acid-dependent ceramide synthesis, both occur not only at pH 4.0 but also at pH 9.0, although normal kidney exhibits these activities only at pH 4.0. Both tissues are capable of snythesizing ceramide via an acyl-COA-dependent pathway at neutral pH. The synthetic analog of ceramide, N-oleoyl-ethanolamine, is a potent inhibitor of ceramidase.

摘要

已表明,法伯病患者的组织特征性地缺乏酸性(pH 4.0)神经酰胺酶。然而,在正常小脑中,神经酰胺的裂解以及逆向反应,即游离脂肪酸依赖性神经酰胺合成,不仅在pH 4.0时发生,在pH 9.0时也会发生,尽管正常肾脏仅在pH 4.0时表现出这些活性。两种组织都能够在中性pH下通过酰基辅酶A依赖性途径合成神经酰胺。神经酰胺的合成类似物N-油酰乙醇胺是神经酰胺酶的有效抑制剂。

相似文献

1
Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.人肾和小脑中的神经酰胺酶与神经酰胺合成。一种新型碱性神经酰胺酶的描述。
Biochim Biophys Acta. 1975 Jul 22;398(1):125-31. doi: 10.1016/0005-2760(75)90176-9.
2
High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.神经酰胺的高效液相色谱法:在人体组织分析中的应用及法伯病中神经酰胺过量的证明
J Lipid Res. 1974 May;15(3):223-6.
3
Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.法伯病患者肾脏和小脑游离神经酰胺的脂肪酸组成。
Lipids. 1973 Jul;8(7):401-6. doi: 10.1007/BF02531715.
4
Ceramidase deficiency in Farber's disease (lipogranulomatosis).法伯病(脂肪肉芽肿病)中的神经酰胺酶缺乏症。
Science. 1972 Dec 8;178(4065):1100-2. doi: 10.1126/science.178.4065.1100.
5
Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.法伯病作为一种神经酰胺沉积症:临床、放射学及生物化学方面
Acta Paediatr Scand. 1978 Jan;67(1):113-9. doi: 10.1111/j.1651-2227.1978.tb16287.x.
6
Studies on the biosynthesis of ceramide. Does the reversed ceramidase reaction yield ceramides?神经酰胺生物合成的研究。逆向神经酰胺酶反应能产生神经酰胺吗?
Hoppe Seylers Z Physiol Chem. 1980 May;361(5):773-9. doi: 10.1515/bchm2.1980.361.1.773.
7
Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide.一种使用C12-NBD-神经酰胺的碱性和中性神经酰胺酶特异性灵敏检测方法。
J Biochem. 1999 Apr;125(4):746-9. doi: 10.1093/oxfordjournals.jbchem.a022345.
8
Metabolism of ceramide-containing endocytotic vesicles in human diploid fibroblasts.人二倍体成纤维细胞中含神经酰胺的内吞小泡的代谢
J Biol Chem. 1982 Mar 25;257(6):3039-44.
9
Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.法布里病患者和对照者成纤维细胞中酸性和碱性神经酰胺酶的底物特异性。
Biochem J. 1982 Aug 1;205(2):419-25. doi: 10.1042/bj2050419.
10
[14C]ceramide synthesis by sphingolipid ceramide N-deacylase: new assay for ceramidase activity detection.鞘脂神经酰胺N-脱酰酶催化的[14C]神经酰胺合成:一种检测神经酰胺酶活性的新方法
Anal Biochem. 1997 Apr 5;247(1):52-7. doi: 10.1006/abio.1997.2022.

引用本文的文献

1
Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases.一类芳基咪唑基脲作为治疗纤维化疾病的强效酸性神经酰胺酶抑制剂的探索。
ACS Omega. 2025 Jul 31;10(31):34747-34761. doi: 10.1021/acsomega.5c03734. eCollection 2025 Aug 12.
2
The relationship between sphingomyelin and ceramide levels and soft neurological signs in ADHD.注意力缺陷多动障碍中鞘磷脂和神经酰胺水平与软性神经体征之间的关系。
J Neural Transm (Vienna). 2025 Jan;132(1):157-168. doi: 10.1007/s00702-024-02831-w. Epub 2024 Sep 9.
3
The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease.
锰转运蛋白 SLC39A8 将碱性鞘磷脂酶 1 与炎症性肠病联系起来。
Nat Commun. 2024 Jun 5;15(1):4775. doi: 10.1038/s41467-024-49049-8.
4
Ceramide on the road to insulin resistance and immunometabolic disorders in transition dairy cows: driver or passenger?神经酰胺在围产期奶牛胰岛素抵抗和免疫代谢紊乱过程中的作用:驱动因素还是过客?
Front Immunol. 2024 Jan 11;14:1321597. doi: 10.3389/fimmu.2023.1321597. eCollection 2023.
5
Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency.酸神经酰胺酶缺乏症小鼠模型中的脊髓性肌萎缩样表型。
Commun Biol. 2023 May 25;6(1):560. doi: 10.1038/s42003-023-04932-w.
6
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors.设计、合成及一系列唑烷酮羧酸酰胺类化合物的生物学评价作为新型酸性神经鞘氨醇酶抑制剂。
J Med Chem. 2020 Dec 24;63(24):15821-15851. doi: 10.1021/acs.jmedchem.0c01561. Epub 2020 Dec 8.
7
Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain.焦虑和抑郁与大鼠脑中神经鞘脂代谢酶活性升高有关。
Cells. 2020 May 17;9(5):1239. doi: 10.3390/cells9051239.
8
Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes.溶酶体酸性神经酰胺酶的下调介导了HMGB1诱导的小鼠冠状动脉心肌细胞迁移和增殖。
Front Cell Dev Biol. 2020 Mar 10;8:111. doi: 10.3389/fcell.2020.00111. eCollection 2020.
9
Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.酸性鞘磷脂酶缺乏症可改善法伯病。
Int J Mol Sci. 2019 Dec 11;20(24):6253. doi: 10.3390/ijms20246253.
10
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.新型基于神经酰胺的癌症治疗药物在个性化医疗时代的应用
Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19.